The variable morphological coexistence of apoptosis and necrosis in human myocardial infarction: Significance for understanding its pathogenesis, clinical course, diagnosis and prognosis

Coronary Artery Disease

Volumn 9, Issue 5, 1998, Pages 291-307

  James, Thomas N ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Enzymatic diagnosis of myocardial infarction; Intermittency of myocardial infarction symptoms; Macrophages; Phagocytosis; Sequential progression of apoptosis to necrosis

Indexed keywords

CELL ENZYME;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOPSY; CELL MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; CYTOLOGY; ENZYME RELEASE; EXTRACELLULAR SPACE; HEART DEATH; HEART INFARCTION; HEART MUSCLE NECROSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MAJOR CLINICAL STUDY; MUSCLE CELL; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0031829710     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199809050-00007     Document Type: Article

References (83)

1. Haider AW, Andreotti F, Thompson GR, Kluft C, Maseri A, Davies GJ. Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction. Circulation 1996; 94:2072-2076.
2. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257.
3. Searle J, Kerr JFR, Bishop CJ. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu 1982; 17:229-259.
4. Itoh G, Tamura J, Suzuki M, Suzuki Y, Ikeda H, Koike M, et al. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 1995; 146:1325-1333.
5. Quaini F, Cigola E, Sala R, Andreoli AM, Giordano G, Lagrasta C, et al. Apoptosis in the infarcted human heart. Basic Appl Myol 1996; 6:241-249.
6. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki L-M. Apoptosis in human acute myocardial infarction. Circulation 1997; 95:320-323.
7. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996; 74: 86-107.
8. James TN, Post HW, Smith FJ. Myocardial infarction in women. Ann Intern Med 1955; 43:153-164.
9. James TN. Anatomy of the coronary arteries. Hagerstown, Maryland: Harper Brothers; 1961.
10. James TN. Arrhythmias and conduction disturbances in acute myocardial infarction. Am Heart J 1962; 64:416-426.
11. James TN, Keyes JW (editors): Etiology of myocardial infarction. Boston: Little, Brown and Company; 1963.
12. James TN. The coronary circulation and conduction system in acute myocardial infarction. Prog Cardiovasc Dis 1968; 10:410-449.
13. James TN, Isobe JH, Urthaler F. Analysis of components in a cardiogenic hypertensive chemoreflex. Circulation 1975; 52:179-192.
14. James TN. De subitaneis mortibus. XXIV. Ruptured interventricular septum and heart block. Circulation 1977; 55:934-946.
15. Dye LE, Urthaler F, MacLean WAH, Russell RO, Rackley CE, James TN. New arterial hypertension during myocardial infarction. South Med J 1978; 71:289-292.
16. James TN. Anatomy of the crista supraventricularis: its importance for understanding right ventricular function, right ventncular infarction and related conditions. J Am Coll Cardiol 1985; 6:1083-1095.
17. James TN. A cardiogenic hypertensive chemoreflex. Anesth Analg 1989; 69:633-646.
18. James TN, Riddick LR. Sudden death due to isolated acute infarction of the His bundle. J Am Coll Cardiol 1990; 15:1183-1187.
19. James TN. Complex causes of fatal myocardial infarction. Circulation 1997; 96:1696-1700.
20. James TN, Alperin JB. Apoptotic myocardial degeneration in thrombotic thrombocytopenic purpura. Apoptosis 1997; 2:384-394.
21. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
22. James TN, Frame B, Schatz IJ. Pathology of cardiac conduction system in Marfan's syndrome. Arch Intern Med 1964; 114:339-343.
23. Peng L, Liu JJ. A novel method for quantitative analysis of apoptosis. Lab Invest 1997; 77: 547-555.
24. James TN, Terasaki F, Pavlovich ER, Vikhert AM. Apoptosis and pleomorphic micromitochondriosis in the sinus nodes surgically excised from five patients with the long QT syndrome. J Lab Clin Med 1993; 122:309-323.
25. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148:2207-2216.
26. Bennett MR, Gibson DF, Schwartz SM, Tait JF. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res 1995; 77:1136-1142.
27. LaDue JS, Nydick I, Ruegsegger P. The effect of acute and chronic ischemia on enzymes of the myocardium. In: James TN, Keyes JW (editors). The etiology of myocardial infarction. Boston: Little, Brown and Company; 1963. pp. 207-223.
28. Collinson PO, Moseley D, Stubbs PJ, Carter GD. Troponin T for the differential diagnosis of ischaemic myocardial damage. Ann Clin Biochem 1993; 30:11-16.
29. Ohman EM, Armstrong PW, Christenson PH, Granger CB, Katus HA, Hamm CW, for the Gusto-11a Investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335:1333-1341.
30. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335:1342-1349.
31. Van de Werf F. Cardiac troponins in acute coronary syndromes. N Engl J Med 1996; 335:1388-1389.
32. Roberts RR, Zalenski RJ, Mensah EK, Rydman U, Ciavarella G, Gussow L, et al. Costs of an emergency department-based accelerated diagnostic protocol vs hospitalization in patients with chest pain. A randomized controlled trial. JAMA 1997; 278:1670-1676.
33. Luscher MS, Thygesen K, Ravkilde J, Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation 1997; 96:2578-2585.
34. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997; 337:1648-1653.
35. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997; 77:314-318.
36. Dissmann R, Linderer T, Schroder R. Estimation of enzymatic infarct size: direct comparison of the marker enzymes creatine kinase and α-hyroxybutyrate dehydrogenase. Am Heart J 1998; 135:1-9.
37. Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998; 31:241-251.
38. Antman EM, Sacks DB, Rifai N, McCabe CH, Cannon CP, Braunwald E. Time to positivity of a rapid bedside assay for cardiac syndromes: a thrombolysis in myocardial infarction (TIMI) 11A substudy. J Am Coll Cardiol 1998; 31: 326-330.
39. Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Ann Intern Med 1986; 105:221-233.
40. Califf RM, O'Neil W, Stack RS, Aronson L, Mark DB, Mantell S, and the TAMI Study Group. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med 1988; 108:658-662.
41. Bakker AJ, Koelemay MJW, Gorgels JPMC, van Vlies B, Smits R, Tijssen JGP, et al. Failure of new biochemical markers to exclude acute myocardial infarction at admission. Lancet 1993; 342:1220-1222.
42. Timmis AD. Will serum enzymes and other proteins find a clinical application in the early diagnosis of myocardial infarction? Br Heart J 1994; 71:309-310.
43. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Methods 1995; 184:39-51.
44. Nolan AC, Clark WA Jr, Karwoski T, Zak R. Patterns of cellular injury in myocardial ischemia determined by monoclonal antimyosin. Proc Natl Acad Sci USA 1983; 80:6046-6050.
45. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 1989; 65:657-670.
46. Baroldi G, Manion WC. Microcirculatory disturbances and human myocardial infarction. Am Heart J 1967; 74:173-178.
47. James TN, Monto RW. Pathology of the cardiac conduction system in thrombotic thrombocytopenic purpura. Ann Intern Med 1966; 65:37-43.
48. Ridolfi RL, Hutchins GM, Bell WR. The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. Ann Intern Med 1979; 91:357-363.
49. Ohman EM, Tardiff BE. Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization. JAMA 1997; 277: 495-497.
50. Cobbaert C, Hermens WT, Kint PP, Klootwijk PJ, Van de Werf F, Simoons ML. Thrombolysis-induced coronary reperfusion causes acute and massive interstitial release of cardiac muscle cell proteins. Cardiovasc Res 1997; 33:147-155.
51. Abdelmeguid AE, Topol EJ. The myth of the myocardial 'infarctlets' during percutaneous coronary revascularization procedures. Circulation 1996; 94:3369-3375.
52. Kong TQ Jr, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 1997; 277:461-466.
53. Lennon SV, Martin SJ, Cotter TG. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Profit 1991; 24:203-214.
54. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenbuck EH, et al. Stretch-induced programmed myocyte cell death. J Clin Invest 1995; 96:2247-2259.
55. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995; 146:3-15.
56. Yamamoto S, Yasui K, Palade PT, James TN. Spontaneous death of isolated rat cardiocytes in culture in association with internucleosomal cleavage of genomic DNA. Apoptosis 1997; 2:178-188.
57. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995; 21:1465-1468.
58. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 1997; 11:457-465.
59. Flynn PD, Byrne CD, Baglin TP, Weissberg PL, Bennett MR. Thrombin generation by apoptotic vascular smooth muscle cells. Blood 1997; 89:4378-4384.
60. Costa JL, Reese TS, Murphy DL. Serotonin storage in platelets: estimation of storage-packet size. Science 1974; 183:537-538.
61. Horwitz D, Sjoerdsma A. Some interrelationships between elevation of blood pressure and angina pectoris. Hypertension XIII. Proceedings of the Council for High Blood Pressure Research. New York: American Heart Association, Inc.; 1965. pp. 39-48.
62. Comroe JH Jr. The location and function of the chemoreceptors of the aorta. Am J Physiol 1939; 127:176-191.
63. Eckstein RW, Shintani F, Rowen HE Jr, Shimomura K, Ohya N. Identification of left coronary blood supply of aortic bodies in anesthetized dogs. J Appl Physiol 1971; 30:488-492.
64. Becker AE. The glomera in the region of the heart and great vessels. Pathol Eur 1966; 1:410-424.
65. Urthaler F, Hageman GR, James TN. Hemodynamic components of a cardiogenic hypertensive chemoreflex in dogs. Circ Res 1978; 42:135-142.
66. Hayashi T, James TN, Buckingham DC. Ultrastructure and immunohistochemistry of the coronary chemoreceptor in human and canine hearts. Am Heart J 1995; 129:946-959.
67. Robertson D, Hollister AS, Forman MB, Robertson RM. Reflexes unique to myocardial ischemia and infarction. J Am Coll Cardiol 1985; 5:99B-104B.
68. Haerem JW. Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease. Atherosclerosis 1972; 15:199-213.
69. Haerem JW. Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden cardiac death. Atherosclerosis 1974; 19:529-541.
70. El-Maraghi N, Genton E. The relevance of platelet and fibrin thromboembolism of the coronary microcirculation, with special reference to sudden cardiac death. Circulation 1980; 62:936-944.
71. Davies MJ, Thomas AC, Knapman PA, Hangartner JR. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986; 73:418-427.
72. James TN. De subitaneis mortibus. XIX. On the cause of sudden death in pheochromocytoma, with special reference to the pulmonary arteries, the cardiac conduction system, and the aggregation of platelets. Circulation 1976; 54:348-356.
73. James TN. Degenerative lesions of a coronary chemoreceptor and nearby neural elements in the hearts of victims of sudden death (16 cases). Trans Am Clin Climatol Assoc 1985; 97:158-174.
74. Murakami Y, Ishinaga Y, Sano K, Kinoshita Y, Kitamura J, Okada S, et al. Circadian release of serotonin across the coronary bed in patients with endothelial dysfunction. Am J Cardiol 1997; 80:214-216.
75. Kattus AA, Gregg DE. Some determinants of coronary collateral blood flow in the open-chest dog. Circ Res 1959; 7:628-642.
76. Schaper W. The collateral circulation of the heart. In: Clinical studies. Amsterdam: North-Holland Publishing Company; 1971.
77. Schaper W, Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circ Res 1996; 79:911-919.
78. Kajstura J, Mansukhani M, Cheng W, Reiss K, Krajewski S, Reed JC, et al. Programmed cell death and expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart. Exp Cell Res 1995; 219:110-121.
79. James TN, Nichols MM, Sapire DW, DiPatre PL, Lopez SM. Complete heart block and fatal right ventricular failure in an infant. Circulation 1996; 93:1588-1600.
80. Katz WE, Gasior TA, Quinlan JJ, Lazar JM, Firestone L, Griffith BP, et al. Immediate effects of lung transplantation on right ventricular morphology and function in patients with variable degrees of pulmonary hypertension. J Am Coll Cardiol 1996; 27:384-391.
81. James TN, St Martin F, Willis PW III, Lohr TO. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, the sinus node and the internodal pathways. Circulation 1996; 93:1424-1438.
82. Balakumaran A, Campbell GA, Moslen MT. Calcium channel blockers induce thymic apoptosis in vivo in rats. Toxicol Appl Pharmacol 1996; 139:122-129.
83. Ruoslahti F. Stretching is good for a cell. Science 1997; 276:1345-1346.